Nexium (Esomeprazole)

Esomeprazole, the active ingredient in Nexium, is a proton pump inhibitor presented as a injectable solution for intravenous use. It treats acid‑related disorders such as gastro‑esophageal reflux disease and is employed in hospital settings for ulcer prevention and H. pylori eradication.

GNH USA supplies Nexium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Nexium, a proton pump inhibitor, is used to manage conditions driven by excess gastric acid production.

- Gastro‑esophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of esophageal irritation. - Erosive esophagitis: accelerates mucosal repair and alleviates pain. - Helicobacter pylori eradication (as part of combination therapy): enhances bacterial clearance when used with antibiotics. - Prevention of NSAID‑induced gastric ulcers: lowers ulcer incidence in patients receiving non‑steroidal anti‑inflammatory drugs.

Adverse reactions may occur with any medication and should be monitored by the prescribing clinician.

Common Side Effects: - Headache: mild to moderate pain often transient. - Diarrhea: loose stools that may resolve with continued therapy. - Nausea: feeling of queasiness, sometimes accompanied by vomiting. - Abdominal pain: discomfort or cramping in the stomach region.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with rash, swelling, and breathing difficulty. - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Low serum magnesium: may cause muscle weakness, tremors, or cardiac arrhythmia. - Elevated liver enzymes: indicates potential hepatic stress. - Stevens‑Johnson syndrome: rare skin and mucous membrane disorder requiring immediate medical attention.

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for potential complications.

- Assess renal function: adjust therapy in patients with significant impairment. - Monitor serum magnesium: periodic testing is advised during prolonged use. - Evaluate hypersensitivity history: avoid if known allergy to esomeprazole or other PPIs. - Use cautiously in hepatic disease: liver dysfunction may affect drug metabolism. - Review concomitant medications: potential interactions may require dose adjustments. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Esomeprazole can alter the pharmacokinetics of several co‑administered drugs; careful review is recommended.

Major Interactions (Avoid): - Atazanavir: reduced absorption leading to therapeutic failure. - Nelfinavir: decreased plasma levels compromising antiviral efficacy. - Clopidogrel: diminished activation, potentially reducing antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: may increase INR and bleeding risk; monitor coagulation parameters. - Digoxin: possible increase in serum concentration; observe for toxicity signs. - Methotrexate: elevated levels may occur, especially at high doses; monitor renal function and drug levels. - HIV protease inhibitors (e.g., ritonavir): altered exposure; consider dose adjustment or alternative therapy.